NHS Greater Glasgow and Clyde

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, NHS Greater Glasgow and Clyde sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

NHS Greater Glasgow and Clyde: 1 sponsored US clinical trial, 1 recruiting.

NHS Greater Glasgow and Clyde sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Heart Failure, with 1 trials.

Mid-pack sponsor footprint

NHS Greater Glasgow and Clyde is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

1 total, page 1 of 1

RECRUITING NA

Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"

NCT05919342

Therapeutic Areas

Heart Failure 1
Cardiovascular Diseases 1

What is open in the NHS Greater Glasgow and Clyde pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Heart Failure (1 trial), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

NHS Greater Glasgow and Clyde: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

NHS Greater Glasgow and Clyde sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share NHS Greater Glasgow and Clyde1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
NHS Greater Glasgow and Clyde sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

NHS Greater Glasgow and Clyde sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this NHS Greater Glasgow and Clyde page

1 registered trials is a research-attention snapshot, not an endorsement of NHS Greater Glasgow and Clyde or any single study.

  • 1 of NHS Greater Glasgow and Clyde's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Heart Failure is the condition NHS Greater Glasgow and Clyde studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

NHS Greater Glasgow and Clyde pipeline card: 1 registered trials from official public datasets.Report a data error.